• Explore /
  • Poster
  • / XELOX with bevacizumab in elderly patients age 75 or older with metastatic colorectal cancer: Results of a planned interim analysis for multicenter phase II ASCA study.

XELOX with bevacizumab in elderly patients age 75 or older with metastatic colorectal cancer: Results of a planned interim analysis for multicenter phase II ASCA study.

Abstract Poster

Authors

null

Keiichiro Ishibashi

Saitama Medical Center, Saitama Medical University

Keiichiro Ishibashi , Yoshinori Munemoto , Masaki Matsuoka , Taishi Hata , Michiya Kobayashi , Junichi Hasegawa , Mutsumi Fukunaga , Akinori Takagane , Toshio Otsuji , Yasuhiro Miyake , Michitaka Nagase , Koji Oba , Junichi Sakamoto , Hideyuki Mishima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000003500

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr502)

DOI

10.1200/jco.2013.31.4_suppl.502

Abstract #

502

Poster Bd #

D2

Abstract Disclosures

Similar Posters

First Author: Hideaki Bando

First Author: Eiji Oki

First Author: Evaristo Maiello

First Author: Satoshi Yuki